Omar Abdel-Wahab, Hematologist/Oncologist, Director of MSK Center for Hematologic Malignancies, and Chair of Molecular Pharmacology Program at Memorial Sloan Kettering Cancer Center, shared a post on LinkedIn by Patricia Santos, Sr. Techical Application Scientist at ImmudexImmudex, adding:
“It’s been amazing working with Immudex to isolate and characterize antigen-specific T cells and T cell receptors! Excited to showcase our collaboration and their technologies in this webinar.”
Quoting Patricia Santos‘s post:
“It was a pleasure to work with Dr. Abdel-Wahab’s team, focused on studying neoantigen-specific T cells using our dCODE® Dextramer reagents. To find out more, check out this upcoming webinar!!”
More posts featuring Omar Abdel-Wahab on OncoDaily.